Eledon Pharmaceuticals (ELDN) Share-based Compensation Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -23.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.11% |
| Dec 31, 2025 | -62.55% |
| Sep 30, 2025 | 36.17% |
| Jun 30, 2025 | -12.05% |
| Mar 31, 2025 | 69.07% |
| Dec 31, 2024 | 284.91% |
| Sep 30, 2024 | 2.83% |
| Jun 30, 2024 | 78.08% |
| Mar 31, 2024 | 22.66% |
| Dec 31, 2023 | 16.01% |
| Sep 30, 2023 | -20.64% |
| Jun 30, 2023 | -25.48% |
| Mar 31, 2023 | -36.83% |
| Dec 31, 2022 | -28.20% |
| Sep 30, 2022 | 6.95% |
| Jun 30, 2022 | 13.47% |
| Mar 31, 2022 | 23.22% |
| Dec 31, 2021 | 23.75% |
| Sep 30, 2021 | 132.69% |
| Jun 30, 2021 | 932.49% |
| Mar 31, 2021 | 305.95% |
| Dec 31, 2020 | 582.72% |
| Sep 30, 2020 | 286.78% |
| Jun 30, 2020 | -68.58% |
| Mar 31, 2020 | 107.11% |
| Dec 31, 2019 | -67.16% |
| Sep 30, 2019 | -4.22% |
| Jun 30, 2019 | 55.20% |
| Mar 31, 2019 | 31.06% |
| Dec 31, 2018 | 283.42% |
| Sep 30, 2018 | 58.00% |
| Jun 30, 2018 | 210.77% |
| Mar 31, 2018 | 51.89% |
| Dec 31, 2017 | 565.52% |
| Sep 30, 2017 | -76.78% |
| Jun 30, 2017 | -86.90% |
| Mar 31, 2017 | -89.63% |
| Dec 31, 2016 | -96.62% |
| Sep 30, 2016 | -19.65% |
| Jun 30, 2016 | 63.70% |
| Mar 31, 2016 | 61.20% |
| Dec 31, 2015 | 45.50% |
| Sep 30, 2015 | -31.81% |
| Jun 30, 2015 | 142.40% |
| Mar 31, 2015 | 604.44% |
| Dec 31, 2014 | 483.17% |
| Sep 30, 2014 | 2,408.51% |